This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 May 27;301(20):2152-3.

doi: 10.1001/jama.2009.729.

Forecasting age-related macular degeneration through 2050

Barbara E K Klein¹, Ronald Klein

Affiliations

Affiliation

¹ Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, 610 N Walnut St, Room 407 WARF, Madison, WI 53726, USA. kleinb@epi.ophth.wisc.edu

PMID: 19475785
DOI: 10.1001/jama.2009.729

Comment

Forecasting age-related macular degeneration through 2050

Barbara E K Klein et al. JAMA. 2009.

. 2009 May 27;301(20):2152-3.

doi: 10.1001/jama.2009.729.

Authors

Barbara E K Klein¹, Ronald Klein

Affiliation

¹ Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, 610 N Walnut St, Room 407 WARF, Madison, WI 53726, USA. kleinb@epi.ophth.wisc.edu

PMID: 19475785
DOI: 10.1001/jama.2009.729

No abstract available

PubMed Disclaimer

Comment on

Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.
Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J; Vision Health Cost-Effectiveness Study Group. Rein DB, et al. Arch Ophthalmol. 2009 Apr;127(4):533-40. doi: 10.1001/archophthalmol.2009.58. Arch Ophthalmol. 2009. PMID: 19365036

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems